In fiscal year 2020, GlaxoSmithKline Pharmaceuticals Limited in India had almost 6.6 billion Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's 6.31 billion rupees worth EBITDA.
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2020 (in billion Indian rupees)*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- GSK Pharmaceuticals' earnings per share in India FY 2015-2020
- GSK Pharmaceuticals' number of employees in India FY 2016-2020
- GSK Pharmaceuticals' CSR expenditure in India 2020 by project
- GSK Pharmaceuticals' CSR expenditure in India 2020 by type
- GSK Pharmaceuticals' market price of shares at NSE India FY 2020 by month
- GSK Pharmaceuticals' shareholder distribution India FY 2020
- GSK Pharmaceuticals' book value per share India FY 2015-2020
- GSK Pharmaceuticals' remuneration of executive directors in India 2020
- GlaxoSmithKline's number of employees by region 2011-2019
- GlaxoSmithKline's revenue by division 2006-2019
- GlaxoSmithKline's expenditure on research and development by sector 2015-2019
- GlaxoSmithKline: cash flow 2006-2019
- GlaxoSmithKline: expenditure on research and development 2006-2019
- GlaxoSmithKline's profit 2006-2019
- Estonia: number of pharmaceutical preparations manufacturers 2008-2016
- U.S. share of life sciences M&A deal value worldwide 2015-2017
- Medicament mixtures not in dosage: UK import value 2001-2019
- Percentage of Elanco revenue by region 2019-2020
- United Kingdom (UK): EU budget public sector receipts 2009/10 to 2017/18
GlaxoSmithKline. (June 24, 2020). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2020 (in billion Indian rupees)* [Graph]. In Statista. Retrieved March 08, 2021, from https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2020 (in billion Indian rupees)*." Chart. June 24, 2020. Statista. Accessed March 08, 2021. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. (2020). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2020 (in billion Indian rupees)*. Statista. Statista Inc.. Accessed: March 08, 2021. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "Ebitda of Gsk Pharmaceuticals Limited in India from Financial Year 2015 to 2020 (in Billion Indian Rupees)*." Statista, Statista Inc., 24 Jun 2020, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline, EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2020 (in billion Indian rupees)* Statista, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/ (last visited March 08, 2021)